Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Bone and Dental

Depression drugs weaken bones in elderly: study

11 years, 10 months ago

1006  0
Posted on Jan 25, 2007, 12 p.m. By Bill Freeman

Older adults who take the most popular class of anti-depressant drugs worsen their risk of developing fragile bones, a study said on Monday. Tests on a group of Canadians aged 50 or older found those taking selective serotonin reuptake inhibitors had 4 percent less bone mineral density in their hip bones. Millions of people take the anti-depressants commonly called SSRIs that include Eli Lilly's Prozac.

Tests on a group of Canadians aged 50 or older found those taking selective serotonin reuptake inhibitors had 4 percent less bone mineral density in their hip bones.

Millions of people take the anti-depressants commonly called SSRIs that include Eli Lilly's Prozac.

The 137 people in the study who took the anti-depressants also doubled their risk of suffering a bone fracture, compared to more roughly 5,000 participants not taking the drugs.

About one in 10 of those who took the anti-depressants fractured a bone over the 5-year study period -- often from minor falls -- said the researchers from McGill University in Montreal, writing in the journal Archives of Internal Medicine.

The doubling of the risk of bone fractures held true even after taking into account the mostly elderly subjects' reduced bone mineral density and higher risk of sustaining falls.

"Fracture rates remain elevated despite adjustment for these two risk factors, indicating that other pathways, such as impaired bone quality leading to reduced bone strength, may be of particular relevance," wrote McGill researcher Brent Richards.

"It's not just the quantity of bone but the quality of the bone," senior study author David Goltzman said in a telephone interview.

While boosting serotonin in the brain lifts the mood of depressed patients, altering the chemical's reabsorption in the body also affects bone development, Goltzman said.

The drugs appear to adversely affect osteoblasts, cells that form bone, resulting in more brittle bones.

Osteoporosis -- the most common condition making bones brittle -- or low bone mass, affects more than half of Americans aged 50 or older, and afflicts four times as many women as men.

Read Full Story

Subscribe to our Newsletter

WorldHealth Videos

WorldHealth Sponsors